NasdaqCM - Delayed Quote
USD
PMGC Holdings Inc. (ELAB)
4.7900
-0.4700
(-8.94%)
At close: April 10 at 4:00:02 PM EDT
4.6500
-0.1400
(-2.92%)
After hours: April 10 at 7:59:52 PM EDT
Loading chart for ELAB
- Previous Close
5.2600 - Open
5.2300 - Bid 3.8600 x 200
- Ask 5.8400 x 200
- Day's Range
4.5200 - 5.4000 - 52 Week Range
1.6200 - 309.8947 - Volume
5,134,601 - Avg. Volume
7,009,234 - Market Cap (intraday)
9.277M - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-382.6100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
pmgcholdings.comRecent News: ELAB
View More
Performance Overview: ELAB
Trailing total returns as of 4/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ELAB
86.51%
S&P 500 (^GSPC)
0.42%
1-Year Return
ELAB
98.23%
S&P 500 (^GSPC)
29.40%
3-Year Return
ELAB
100.00%
S&P 500 (^GSPC)
65.90%
5-Year Return
ELAB
100.00%
S&P 500 (^GSPC)
65.11%
Statistics: ELAB
View MoreValuation Measures
As of 4/9/2026
-
Market Cap
10.26M
-
Enterprise Value
6.94M
-
Trailing P/E
0.00
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
0.18
-
Price/Book (mrq)
1.31
-
Enterprise Value/Revenue
11.75
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-40.73%
-
Return on Equity (ttm)
-107.34%
-
Revenue (ttm)
590.08k
-
Net Income Avi to Common (ttm)
-7.78M
-
Diluted EPS (ttm)
-382.6100
Balance Sheet and Cash Flow
-
Total Cash (mrq)
6.07M
-
Total Debt/Equity (mrq)
33.75%
-
Levered Free Cash Flow (ttm)
-2.76M
Compare To: ELAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: ELAB
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
